Factors associated with measles vaccine immunogenicity in children at University Teaching Hospitals, Lusaka, Zambia
- PMID: 40267112
- PMCID: PMC12017566
- DOI: 10.1371/journal.pgph.0003954
Factors associated with measles vaccine immunogenicity in children at University Teaching Hospitals, Lusaka, Zambia
Abstract
Measles poses a significant global public health challenge, particularly in low-resource settings where vaccination coverage is limited. This study examined factors associated with measles vaccine immunogenicity in children aged 2-15 years at the University Teaching Children's Hospital and the HIV Pediatric Centre of Excellence in Lusaka, Zambia. This comparative analytical cross-sectional study was conducted from April to July 2024, enrolling 200 children, including 100 HIV-positive and 100 HIV-negative participants. All children had received at least two doses of a measles-containing vaccine and had no history of measles infection in the past six months. Blood samples were analyzed for measles immunity, while data on age, HIV status, breastfeeding history, and socio-demographic factors were collected. Among HIV-negative children, 75% retained immunity, whereas only 38% of HIV-positive children retained immunity. Multivariate logistic regression showed that children aged 10-15 years were less likely to retain immunity compared to those aged 2-4 years (AOR = 0.270, 95% CI [0.114-0.618], p = 0.002). HIV-positive children had lower odds of retaining immunity compared to HIV-negative children (AOR = 0.290, 95% CI [0.137-0.594], p < 0.001). Breastfed children had higher immunity retention (AOR = 0.336, 95% CI [0.147-0.738], p = 0.007) compared to non-breastfed children. Residing in Lusaka was associated with lower immunity retention (AOR = 0.250, 95% CI [0.066-0.859], p = 0.031). These findings highlight the protective role of breastfeeding and suggest that older and HIV-infected children may benefit from booster doses to sustain measles immunity.
Copyright: © 2025 Gardner et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey.Lancet. 2009 Mar 21;373(9668):1025-32. doi: 10.1016/S0140-6736(09)60142-2. Epub 2009 Feb 9. Lancet. 2009. PMID: 19211140
-
Measles infection in hospitalized children in Lusaka, Zambia.Ann Trop Paediatr. 1995 Jun;15(2):167-72. doi: 10.1080/02724936.1995.11747767. Ann Trop Paediatr. 1995. PMID: 7677420
-
Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study.J Infect Dis. 2007 Aug 1;196(3):347-55. doi: 10.1086/519169. Epub 2007 Jun 19. J Infect Dis. 2007. PMID: 17597448
-
Immunogenicity and Safety of the Measles Vaccine in HIV-Infected Children: An Updated Systematic Review.Am J Epidemiol. 2019 Dec 31;188(12):2240-2251. doi: 10.1093/aje/kwz144. Am J Epidemiol. 2019. PMID: 31210268
-
Vaccines for measles, mumps, rubella, and varicella in children.Cochrane Database Syst Rev. 2020 Apr 20;4(4):CD004407. doi: 10.1002/14651858.CD004407.pub4. Cochrane Database Syst Rev. 2020. Update in: Cochrane Database Syst Rev. 2021 Nov 22;11:CD004407. doi: 10.1002/14651858.CD004407.pub5. PMID: 32309885 Free PMC article. Updated.
References
-
- World Health Organization, UNICEF. Weekly epidemiological record: world health organization measles fact sheet. 2021. Available from: https://www.who.int/publications/i/item/weekly-epidemiological-record
-
- Ministry of Health Zambia. HMIS. Lusaka; 2023.
LinkOut - more resources
Full Text Sources
Miscellaneous